Clinical effectiveness of group cognitive-behavioural therapy for depressed older people in primary care. A randomised controlled trial

被引:6
|
作者
Garcia-Pena, Carmen [1 ]
Vazquez-Estupinan, Felipe [2 ]
Avalos-Perez, Fabian [3 ]
Robles Jimenez, Leslie Viridiana [1 ]
Sanchez-Garcia, Sergio [1 ]
Juarez-Cedillo, Teresa [1 ]
机构
[1] IMSS, Unidad Invest Epidemiol & Serv Salud, Area Envejecimiento, CMN SXXI, Mexico City, DF, Mexico
[2] IMSS, CMN SXXI, Hosp Especialidades, Serv Psiquiatria, Mexico City, DF, Mexico
[3] IMSS, Unidad Med Familiar 10, Mexico City, DF, Mexico
关键词
Elderly; depression; cognitive therapy; LATE-LIFE; HEALTH; VALIDATION; SYMPTOMS; VERSION; ADULTS; SF-36; PHQ-9;
D O I
10.17711/SM.0185-3325.2015.004
中图分类号
R749 [精神病学];
学科分类号
100205 ;
摘要
Background Depression is associated with an increased use of medical resources and reduced quality of life, cognitive functions, functionality and general health. The treatment of depression is limited by the scarcity of mental health professionals, as reflected in the mental health atlas of the World Health Organization. Method A randomised controlled trial that was not blinded was conducted. Family doctors referred patients older than 60 years who were suspected to have depression to the screening module. The PHQ-9 questionnaire, the Six-Item Screener, and previous diagnosis for psychiatric disorders were collected. Major depression was excluded. Those with a score from two to six on the PHQ-9 and with no comorbidities were referred to the Baseline Phase. A simple random process without blocking was applied. Groups of 7-10 participants engaged in weekly sessions over the course of three months. The control group was referred to their family physician. Reduction in depression score of the PHQ-9 was the main outcome. Results and discussion There were 40 patients in the control group (CG) and 41 in the intervention group (IG). 84% were women, 41% married and 41% reported at least primary education. The mean age for the GC was 69.7 years vs. 71.3 in the GI. The baseline mean MMSE score was 23.7 in the GC and 24.1 in the IG. No significant baseline differences between groups were reported. In the IG, 56% of the participants (n=23) displayed a decrease that was greater than or equal to 5 points on the PHQ-9 compared with 30% (n=12) in the control group. The CT group evidenced a marginal improvement.
引用
收藏
页码:33 / 39
页数:7
相关论文
共 50 条
  • [21] The heart & mind trial: intervention with cognitive-behavioural therapy in patients with cardiac disease and anxiety: randomised controlled trial protocol
    Berg, Selina Kikkenborg
    Herning, Margrethe
    Schjodt, Inge
    Thorup, Charlotte Brun
    Juul, Carsten
    Svendsen, Jesper Hastrup
    Jorgensen, Martin Balslev
    Risom, Signe Stelling
    Christensen, Signe Westh
    Thygesen, Lau
    Rasmussen, Trine Bernholdt
    BMJ OPEN, 2021, 11 (12):
  • [22] One-day cognitive-behavioural therapy self-confidence workshops for people with depression: randomised controlled trial
    Horrell, Linda
    Goldsmith, Kimberley A.
    Tylee, Andre T.
    Schmidt, Ulrike H.
    Murphy, Caroline L.
    Bonin, Eva-Maria
    Beecham, Jennifer
    Kelly, Joanna
    Raikundalia, Shriti
    Brown, June S. L.
    BRITISH JOURNAL OF PSYCHIATRY, 2014, 204 (03) : 224 - 235
  • [23] Cognitive-behavioural therapy for adult attention-deficit hyperactivity disorder: a proof of concept randomised controlled trial
    Dittner, A. J.
    Hodsoll, J.
    Rimes, K. A.
    Russell, A. J.
    Chalder, T.
    ACTA PSYCHIATRICA SCANDINAVICA, 2018, 137 (02) : 125 - 137
  • [24] A chatbot to improve adherence to internet-based cognitive-behavioural therapy among workers with subthreshold depression: a randomised controlled trial
    Yasukawa, Sakiko
    Tanaka, Taku
    Yamane, Kenji
    Kano, Ritsuko
    Sakata, Masatsugu
    Noma, Hisashi
    Furukawa, Toshi A.
    Kishimoto, Takuya
    BMJ MENTAL HEALTH, 2024, 27 (01):
  • [25] Chat- and internet-based cognitive-behavioural therapy in treatment of adolescent depression: randomised controlled trial
    Topooco, Naira
    Berg, Matilda
    Johansson, Sofie
    Liljethorn, Lina
    Radvogin, Ella
    Vlaescu, George
    Nordgren, Lise Bergman
    Zetterqvist, Maria
    Andersson, Gerhard
    BJPSYCH OPEN, 2018, 4 (04): : 199 - 207
  • [26] Effectiveness of transdiagnostic group cognitive-behavioural therapy for anxiety disorders in a naturalistic clinical setting
    Jiang, Michelle Y. W.
    Kandris, Evelyn
    El-Masry, Yasmeen
    Drobny, Juliette
    St. Clare, Tamsen
    Chen, Jessamine T. H.
    CLINICAL PSYCHOLOGIST, 2021, 25 (01) : 69 - 77
  • [27] Group-based cognitive-behavioural anger management for people with mild to moderate intellectual disabilities: cluster randomised controlled trial
    Willner, Paul
    Rose, John
    Jahoda, Andrew
    Kroese, Biza Stenfert
    Felce, David
    Cohen, David
    MacMahnon, Pamela
    Stimpson, Aimee
    Rose, Nicola
    Gillespie, David
    Shead, Jennifer
    Lammie, Claire
    Woodgate, Christopher
    Townson, Julia
    Nuttall, Jacqueline
    Hood, Kerenza
    BRITISH JOURNAL OF PSYCHIATRY, 2013, 203 (04) : 288 - 296
  • [28] Longer term outcome of cognitive-behavioural and psychodynamic psychotherapy in routine mental health care: Randomised controlled trial
    Watzke, Birgit
    Rueddel, Heinz
    Juergensen, Ralph
    Koch, Uwe
    Kriston, Levente
    Grothgar, Barbara
    Schulz, Holger
    BEHAVIOUR RESEARCH AND THERAPY, 2012, 50 (09) : 580 - 587
  • [29] Exploring patients' reasons for declining contact in a cognitive behavioural therapy randomised controlled trial in primary care
    Barnes, Maria
    Wiles, Nicola
    Morrison, Jill
    Kessler, David
    Williams, Chris
    Kuyken, Willem
    Lewis, Glyn
    Turner, Katrina
    BRITISH JOURNAL OF GENERAL PRACTICE, 2012, 62 (598) : e371 - e377
  • [30] Transdiagnostic group cognitive behavioural therapy for emotional disorders in primary care: the results of the PsicAP randomized controlled trial
    Cano-Vindel, Antonio
    Munoz-Navarro, Roger
    Moriana, Juan A.
    Ruiz-Rodriguez, Paloma
    Adrian Medrano, Leonardo
    Gonzalez-Blanch, Cesar
    PSYCHOLOGICAL MEDICINE, 2022, 52 (15) : 3336 - 3348